Volume 2, Issue 6: Title of Issue:THE NEW AGENTS FOR DIABETES: THE MEANING OF SAFETY
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 2, Issue 6)
Nurses and health care professionals involved in the care of patients with diabetes.
After participating in this activity, the participant will demonstrate the ability to describe new findings in:
- Describe the risks and benefits of incretin-based agents.
- Evaluate the benefits and safety issues associated with SGLT2 inhibitors.
- Explain how “safety” of glycemic-control agents should be determined by balancing the longer-term risks of a treatment against its potential benefits.
- 1.00 ANCC
- 1.00 Attendance